3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
4
Terminated
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, B-Cell
3
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Teratoma
1
Seminoma
1
Sarcoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Osteosarcoma
1
Nonseminomatous germ cell tumor
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lymphoma, T-Cell
1
Lymphoma, Primary Effusion
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, AIDS-Related
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hodgkin Disease
1
Histiocytosis, Langerhans-Cell
1
Interventions
Cyclophosphamide
16
Vincristine
12
Prednisone
11
Methotrexate
11
Etoposide
9
Cytarabine
9
merphos
8
blinatumomab
8
venetoclax
7
prednylidene
7
pegaspargase
7
deltacortene
7
Specimen Handling
7
Mercaptopurine
7
Dexamethasone
7
azathiopurine
6
N,N-dicyclohexyl-isoborneol-10-sulfonamide
6
Doxorubicin
6
Calcium Dobesilate
6
dexamethasone acetate
5
dexamethasone 21-phosphate
5
auricularum
5
Spinal Puncture
5
Rituximab
5
Leucovorin
5
Biopsy
5
fludarabine phosphate
4
Stem Cell Transplantation
4
Methylprednisolone
4
Inotuzumab Ozogamicin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Burkitt Lymphoma
×
etoposide phosphate
×
Clear all
NCT05270057
2025-10-09
LONCA
Medical College of Wisconsin
Phase 1
Active not recruiting
11 enrolled